Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

AB+ blood group is more common in alopecia areata patients.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

High-resolution MRI can distinguish between tertiary androgenetic alopecia and severe alopecia areata by measuring scalp and tissue thickness and hair follicle depth.

Different fish use the same genes to regrow teeth.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Hair absorbs alkali bromide salts and water, affecting its structure, with absorption decreasing at higher temperatures.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

COVID-19 doesn't make alopecia areata worse.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Topical tofacitinib is effective and safe for treating alopecia areata.